Clindesse is a Vaginal Cream in the Human Prescription Drug category. It is labeled and distributed by Padagis Israel Pharmaceuticals Ltd. The primary component is Clindamycin Phosphate.
| Product ID | 45802-042_0640a4a5-8ff8-4fd5-a25c-9ae321af586e |
| NDC | 45802-042 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Clindesse |
| Generic Name | Clindamycin Phosphate |
| Dosage Form | Cream |
| Route of Administration | VAGINAL |
| Marketing Start Date | 2015-07-03 |
| Marketing Category | NDA / NDA |
| Application Number | NDA050793 |
| Labeler Name | Padagis Israel Pharmaceuticals Ltd |
| Substance Name | CLINDAMYCIN PHOSPHATE |
| Active Ingredient Strength | 100 mg/5g |
| Pharm Classes | Decreased Sebaceous Gland Activity [PE],Lincosamide Antibacterial [EPC],Lincosamides [CS],Neuromuscular Blockade [PE] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2015-07-03 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA050793 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2015-07-03 |
| Marketing Category | NDA |
| Application Number | NDA050793 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-07-03 |
| Ingredient | Strength |
|---|---|
| CLINDAMYCIN PHOSPHATE | 100 mg/5g |
| SPL SET ID: | fe8bb204-f173-44fe-803b-b08f2ec5aa31 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 45802-042 | Clindesse | Clindesse |
| 64011-124 | Clindesse | Clindesse |
| 0009-0302 | Cleocin Phosphate | clindamycin phosphate |
| 0009-0602 | Cleocin Phosphate | clindamycin phosphate |
| 0009-0728 | Cleocin Phosphate | clindamycin phosphate |
| 0009-0775 | Cleocin Phosphate | clindamycin phosphate |
| 0009-0870 | Cleocin Phosphate | clindamycin phosphate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() CLINDESSE 78499863 3184560 Live/Registered |
PERRIGO PHARMA INTERNATIONAL DESIGNATEDACTIVITY COMPANY 2004-10-14 |